Research Article
Metadichol®: A Novel Nanolipid Formulation That Inhibits SARS-CoV-2 and a Multitude of Pathological Viruses In Vitro
| Sample | Concentration (μg/mL) | RFU | % inhibition | IC50 (μg/mL) |
| Control | 0 | 308315546 | 0.00 | |
| Metadichol | 0.125 | 290309918 | 5.84 | 30.15 | 0.25 | 260064163 | 15.65 | | 0.5 | 249149792 | 19.19 | | 1 | 240301136 | 22.06 | | 10 | 212275253 | 31.15 | | 20 | 187702504 | 39.12 | | 40 | 139821100 | 54.65 | |
| DX600 | 0.0156 | 252855648 | 17.99 | 0.1027 | 0.031 | 231028864 | 25.07 | | 0.0625 | 193810784 | 37.14 | | 0.125 | 145881248 | 52.68 | | 0.25 | 127485752 | 58.65 | | 0.5 | 111498760 | 63.84 | |
|
|